María Elvira Garrido-Lestache Rodríguez -Monte

Dr. María Elvira Garrido-Lestache Rodríguez -Monte

Ramon y Cajal University Hospital, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Journal of Hepatology
Verified
Journal Article
Closed access
LTLuis Téllez
Luis Téllez
ESEnrique Rodríguez de Santiago
Enrique Rodríguez de Santiago
BMBeatriz Mínguez
Beatriz Mínguez
APAudrey Payance
Audrey Payance
ACAna Clemente
Ana Clemente
MMMarta Magaz
Marta Magaz

10 September 2024 in Journal of Hepatology
Verified
Journal Article
Closed access
LTLuis Téllez
Luis Téllez
DRDiego Rincón
Diego Rincón
APAudrey Payancé
Audrey Payancé
AJAnaïs Jaillais
Anaïs Jaillais
PLPascal Lebray
Pascal Lebray
AAAgustín Albillos
Agustín Albillos

8 April 2025 in Cancer Discovery
Verified
Journal Article
Open access
CACarlota Arenillas
Carlota Arenillas
LCLucía Celada
Lucía Celada
JRJosé Ruiz-Cantador
José Ruiz-Cantador
BCBruna Calsina
Bruna Calsina
DDDebayan Datta
Debayan Datta
RTRodrigo Toledo
Rodrigo Toledo
This study explores parallels between systemic hypoxia adaptation in high-altitude populations and tumorigenesis. We identified EPAS1, a gene critical for hypoxia adaptation in populations such as Tibetans and Sherpas, as playing a similar adaptive role in tumors arising under hypoxic conditions. Tumors from patients with chronic hypoxia displayed impaired DNA repair and frequent emergence of EPAS1 variants, with frequencies reaching up to 90%, echoing the positive selection seen in high-altitude dwellers. Mechanistically, EPAS1 gain-of-function mutations promote COX4I2 expression, reducing cellular oxygen consumption and supporting tumor proliferation in hypoxia. Analysis of clinical data from patients with hypoxia revealed tissue-specific and time-sensitive tumorigenic effects, particularly impacting oxygen-sensitive cells in the postnatal period. Our findings suggest that EPAS1-driven adaptation mechanisms in high-altitude populations provide a model for understanding tumor evolution under hypoxic stress, highlighting how genetic adaptations to diverse stressors in natural populations may yield insights into tumorigenesis and cancer progression. Significance: This study reveals a broad convergence in genetic adaptation to hypoxia between natural populations and tumors, suggesting that insights from natural populations could enhance our understanding of cancer biology and identify novel therapeutic targets. See related commentary by Lee, p. 875

Verified
Journal Article
Open access
PDF file
ACAlejandro Cruz-Utrilla
Alejandro Cruz-Utrilla
NGNatalia Gallego
Natalia Gallego
JTJair Antonio Tenorio
Jair Antonio Tenorio
IRInmaculada Guillén Rodríguez
Inmaculada Guillén Rodríguez
ATAlba Torrent-Vernetta
Alba Torrent-Vernetta
MMMaría Jesús del Cerro Marín
María Jesús del Cerro Marín
Background: Pulmonary arterial hypertension (PAH) is a severe and rare disease with an important genetic background. The influence of genetic testing in the clinical classification of pediatric PAH is not well known and genetics could influence management and prognosis. Objectives: The aim of this work was to identify the molecular fingerprint of PH children in the REgistro de pacientes con HIpertensión Pulmonar PEDiátrica (REHIPED), and to investigate if genetics could have an impact in clinical reclassification and prognosis. Methods: We included pediatric patients with a genetic analysis from REHIPED. From 2011 onward, successive genetic techniques have been carried out. Before genetic diagnosis, patients were classified according to their clinical and hemodynamic data in five groups. After genetic analysis, the patients were reclassified. The impact of genetics in survival free of lung transplantation was estimated by Kaplan–Meier curves. Results: Ninety-eight patients were included for the analysis. Before the genetic diagnoses, there were idiopathic PAH forms in 53.1%, PAH associated with congenital heart disease in 30.6%, pulmonary veno-occlusive disease—PVOD—in 6.1%, familial PAH in 5.1%, and associated forms with multisystemic disorders—MSD—in 5.1% of the patients. Pathogenic or likely pathogenic variants were found in 44 patients (44.9%). After a genetic analysis, 28.6% of the cohort was “reclassified”, with the groups of heritable PAH, heritable PVOD, TBX4, and MSD increasing up to 18.4%, 8.2%, 4.1%, and 12.2%, respectively. The MSD forms had the worst survival rates, followed by PVOD. Conclusions: Genetic testing changed the clinical classification of a significant proportion of patients. This reclassification showed relevant prognostic implications.

22 July 2025 in Hepatology
Verified
Journal Article
Closed access
LTLuis Téllez
Luis Téllez
MTMaría Toledano
María Toledano
MÁMaría Álvarez
María Álvarez
M-María Elvira Garrido-Lestache Rodríguez -Monte
María Elvira Garrido-Lestache Rodríguez -Monte
EGElena Garrido
Elena Garrido
AAAgustín Albillos
Agustín Albillos
Background and Aims: Esophageal varices (EV) are common in adults with Fontan-type circulation and may arise via distinct hemodynamic mechanisms depending on their anatomic location. We aimed to determine the prevalence, anatomical distribution, and hemodynamic correlates of EV in this population. Approach and Results: In this prospective cohort study, 114 consecutive adults with Fontan-type circulation underwent combined hepatic and cardiac catheterization, esophagogastroduodenoscopy, and liver biopsy. Patients were classified by endoscopic findings into those with and without EV, and the EV cohort was further stratified by location (proximal or distal). EV were present in 36.8% (95% CI, 27.9–45.8%), including 28.9% with distal EV and 17.5% with proximal EV. Over a median follow-up of 48.9 months (IQR, 27.1–85.5), only one variceal bleeding event occurred. Patients with distal EV exhibited the highest cardiac index and pulmonary, systemic and hepatic venous pressures, as well as the lowest systemic vascular resistance (all p <0.01). Severe hepatic fibrosis was more frequent in this group (87.9%) than in patients without EV (33.8%) or those with proximal EV (25.0%). Non-invasive fibrosis markers (liver stiffness, FIB-4, Forns index, FonLiver risk score) were significantly elevated in patients with distal EV (all p <0.05), despite similar biochemical profiles. Conclusions: Distal EVs are frequent and characterize a distinct hemodynamic phenotype, featuring elevated Fontan pathway pressures, severe hepatic fibrosis, portal hypertension, and a hyperdynamic circulatory state.

3 December 2025
Verified
Journal Article
Open access
JPJosé Manuel Puyana-Rodríguez
José Manuel Puyana-Rodríguez
MGMercedes Guida-Piqueras
Mercedes Guida-Piqueras
ENEnrique Navas-Elorza
Enrique Navas-Elorza
IMIsabel Molina-Borao
Isabel Molina-Borao
NRNatalia Rivero-Jiménez
Natalia Rivero-Jiménez
MÁMaría Álvarez-Fuente
María Álvarez-Fuente